Anita Shet, MD
Anita Shet is a pediatric infectious diseases specialist with broad interests in childhood infections in low- and middle-income countries with a specific focus on vaccine-preventable infections. Her interests include clinical epidemiology and immunology of dengue infections in infants and children. She leads a multicenter study on surveillance of invasive pneumococcal infections and clinical pneumonia in children, and is evaluating the impact of the pneumococcal conjugate vaccine rollout in India. Her research also explores the link between timely immunization and cognitive outcomes in children. She has experience in the care of children living with HIV, and her previous research has explored drug adherence and treatment outcomes in HIV using complex interventions designed to modify behavior. Her interests include studying the interactions of nutrition and infection, and her previous studies explored the effect of iron supplementation in HIV-infected children with anemia and inflammation. She currently serves on the Council of the International Congress of Infectious Diseases, and is member of the Dengue Vaccines Advisory Committee on Immunization Practices (ACIP) Workgroup. She also serves on the National Institutes of Health (NIH) Candidate Vaccine Advisory Committee and the Steering Group on Epidemiological Preparation for Vaccine Trials established by the Indo-US Vaccine Action Program to provide guidance on epidemiological and vaccine studies for dengue and chikungunya control in India.
Resources:
Effect of mobile telephone reminders on treatment outcome in HIV
Childhood immunisations in India during the COVID-19 pandemic
Get to Know Three of our 2024-2025 Social & Behavioral Research Grant Partners (Part 2)
Sabin Vaccine Institute introduces three of the new 2024-2025 cohort of Social and Behavioral Research Grant Partners.
Bridging the Immunization Gap: Community-Driven Strategies for Enhanced Vaccine Coverage
The fifth cohort of the Social & Behavioral Grants program will focus on addressing the challenges faced by zero-dose children and their families.
Get to Know Three of our 2024-2025 Social & Behavioral Research Grant Partners (Part 1)
Sabin Vaccine Institute introduces three of the new 2024-2025 cohort of Social and Behavioral Research Grant Partners.
VARN2023 Conference Report (French)
Quand les communautés dirigent, l’immunisation mondiale réussit